Endometrial, breast, ovarian, and colorectal cancers – can obesity be a risk factor for their development?

Kinga Bodziony; Aleksandra Komoń; Anna Pszonka; Damian Ujazda; Jan Wójtowicz; Mateusz Tyniec; Kamal Morshed

doi:10.2478/bgbl-2024-0040

Abstract

Obesity is recognized as one of the major risk factors for the development of malignant tumors. This article presents evidence that excessive body weight increases the risk of various types of cancer. The mechanisms through which obesity influences carcinogenesis, such as hormonal dysregulation, inflammation, and metabolic changes, are identified. Potential health interventions that could help reduce cancer risk in individuals with obesity are also considered.

References

Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011; 11(12): 886–895. doi: 10.1038/nrc3174.
Search in Google Scholar Back to article
Owiecki M. Otyłość epidemią XXI wieku. Przegląd Kardiodiabetologiczny. 2009; 36–41.
Search in Google Scholar Back to article
Ahima RS, Flier JS. Leptin and the regulation of body weight in mammals. N Engl J Med. 2000; 341(13): 909-915.
Search in Google Scholar Back to article
Goday A, Barneto I, García-Almeida JM, et al. Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2015; 17(10): 763–771. doi: 10.1007/s12094-015-1306-y.
Search in Google Scholar Back to article
Siemińska L. Tkanka tłuszczowa. Patofizjologia, rozmieszczenie, różnice płciowe oraz znaczenie w procesach zapalnych i nowotworowych. Endokrynol Pol. 2007; 58(4): 330–343.
Search in Google Scholar Back to article
Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1): 79–83.
Search in Google Scholar Back to article
Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008; 8(12): 915-928. doi: 10.1038/nrc2536.
Search in Google Scholar Back to article
Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010; 21(10): 610-618. doi: 10.1016/j.tem.2010.06.007.
Search in Google Scholar Back to article
Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/ insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009; 30(6): 586-623. doi: 10.1210/er.2008-0047.
Search in Google Scholar Back to article
Subbaramaiah K, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res. 2011; 4(3): 329–346.
Search in Google Scholar Back to article
Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4(8): 579–591.
Search in Google Scholar Back to article
Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: The estrogen connection. Endocrinology. 2009; 150(6): 2537–2542.
Search in Google Scholar Back to article
Pasquali R, et al. Pathophysiology of obesity in polycystic ovary syndrome: Role of adiposity and insulin resistance. J Endocrinol Invest. 2006; 29(3): 54–62.
Search in Google Scholar Back to article
Schindler AE. Progestogen deficiency and endometrial cancer risk. Maturitas. 2009; 4: 334-337.
Search in Google Scholar Back to article
Emons G, Fleckenstein G, Hinney B, et al. Hormonal interactions in endometrial cancer. Endocr Relat Cancer. 2000; 4: 227-242.
Search in Google Scholar Back to article
Duleba AJ, Dokras A. Is PCOS an inflammatory process? Fertil Steril. 2012; 97: 7–12.
Search in Google Scholar Back to article
Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013; 78: 782–785.
Search in Google Scholar Back to article
Bryant W, Snowhite AE, Rice LW, Shupnik MA. The estrogen receptor (ER)α variant Δ5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells. Endocrinology. 2005; 2: 751-759.
Search in Google Scholar Back to article
Foksiński M, Piekutowski M, Roszkowski K, Oliński R. Rola estrogenów w procesie karcinogenezy. Współcz Onkol. 2002; 3: 137-140.
Search in Google Scholar Back to article
Bardia A, Vachon CM, Olson JE, et al. Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17: 374-8.
Search in Google Scholar Back to article
Micozzi MS. Cross-cultural correlations of childhood growth and adult breast cancer. Am J Phys Anthropol. 1987; 73: 525-37.
Search in Google Scholar Back to article
Brinton LA, Schairer C, Hoover RN. Menstrual factors and risk of breast cancer. Cancer Invest. 2001; 6: 245-54.
Search in Google Scholar Back to article
Willis D. Does estrogen replacement therapy reduce the risk of fatal breast cancer in postmenopausal women? Maturitas. 1997; 37: 105-108.
Search in Google Scholar Back to article
Makowski M, Połać I, Pertyński T. Estrogeny a rak sutka. Prz Menopauz. 2007; 3: 150–154.
Search in Google Scholar Back to article
Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003; 22: 5108-21.
Search in Google Scholar Back to article
Grodecka-Gazdecka S. Association between obesity and breast cancer. Forum Zaburzeń Metabolicznych. 2011; 4(2): 231-238.
Search in Google Scholar Back to article
Jarde T, Perrier S, Vasson MP, et al. Molecular mechanism of leptin and adiponectin. Eur J Cancer. 2011; 47: 33-34.
Search in Google Scholar Back to article
Consedine NS, Magai C, Conway F, et al. Obesity and awareness of obesity as risk factors for breast cancer in six ethnic groups. Obes Res. 2004; 12: 1680–9.
Search in Google Scholar Back to article
Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997; 216: 28–43.
Search in Google Scholar Back to article
Roszak M, Litwiniuk M, Gazdecka S. Otyłość a rak piersi. Współcz Onkol. 2010; 14(4): 270-275.
Search in Google Scholar Back to article
Rosato V, Bosetti C, Talamini R, et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol. 2011; 22(12): 2687-2692.
Search in Google Scholar Back to article
Purdie D, Green A. Epidemiology of ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2001; 15(3): 355-370.
Search in Google Scholar Back to article
Au CC, et al. The role of adipokines in ovarian cancer cell proliferation and migration. Int J Oncol. 2009; 35(5): 1151-1159.
Search in Google Scholar Back to article
Kyrgiou M, et al. Adiposity and cancer at major anatomical sites: Umbrella review of the literature. BMJ. 2015; 350: g7647.
Search in Google Scholar Back to article
Schouten LJ, Rivera C, Hunter DJ, et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev. 2008; 17: 902-912.
Search in Google Scholar Back to article
Marchesi JR, Dutilh BE, Hall N, et al. Towards the Human Colorectal Cancer Microbiome. PLoS ONE. 2011; 6: e204–247.
Search in Google Scholar Back to article
Nowak A, Libudzisz Z. Karcynogenna aktywność mikroorganizmów jelitowych. Żywność. Nauka. Technologia. Jakość. 2008; 6: 25–39.
Search in Google Scholar Back to article
Tilg H, Kaser A. Gut microbiome, obesity and metabolic syndrome. J Clin Invest. 2011; 121: 2126–2132.
Search in Google Scholar Back to article
Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight R. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005; 102: 11070–11075.
Search in Google Scholar Back to article

Endometrial, breast, ovarian, and colorectal cancers – can obesity be a risk factor for their development?

Abstract

Paradigm

My account